Monoclonal antibodies to human colon and colorectal carcinoma.

por Thompson, C. H., Jones, S. L., Pihl, E., McKenzie, I. F.
Publicado 1983

Purification and biochemical characterisation of a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2.

por Stacker, S. A., Tjandra, J. J., Xing, P. X., Walker, I. D., Thompson, C. H., McKenzie, I. F.
Publicado 1989

Evaluation of MSA as a serum marker in breast cancer: a comparison with CEA.

por Stacker, S. A., Sacks, N. P., Golder, J., Tjandra, J. J., Thompson, C. H., Smithyman, A., McKenzie, I. F.
Publicado 1988

Comparison of mammary serum antigen (MSA) and CA15-3 levels in the serum of patients with breast cancer.

por Sacks, N. P., Stacker, S. A., Thompson, C. H., Collins, J. P., Russell, I. S., Sullivan, J. A., McKenzie, I. F.
Publicado 1987

Bryostatin 1, a novel antineoplastic agent and protein kinase C activator, induces human myalgia and muscle metabolic defects: a 31P magnetic resonance spectroscopic study.

por Hickman, P. F., Kemp, G. J., Thompson, C. H., Salisbury, A. J., Wade, K., Harris, A. L., Radda, G. K.
Publicado 1995

Modulation of bryostatin 1 muscle toxicity by nifedipine: effects on muscle metabolism and oxygen supply.

por Thompson, C. H., Macaulay, V. M., O'Byrne, K. J., Kemp, G. J., Wilner, S. M., Talbot, D. C., Harris, A. L., Radda, G. K.
Publicado 1996

The detection of axillary lymph node metastases from breast cancer by radiolabelled monoclonal antibodies: a prospective study.

por Tjandra, J. J., Sacks, N. P., Thompson, C. H., Leyden, M. J., Stacker, S. A., Lichtenstein, M., Russell, I. S., Collins, J. P., Andrews, J. T., Pietersz, G. A.
Publicado 1989

Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer

por Propper, D J, Levitt, N C, O'Byrne, K, Braybrooke, J P, Talbot, D C, Ganesan, T S, Thompson, C H, Rajagopalan, B, Littlewood, T J, Dixon, R M, Harris, A L
Publicado 2000